# Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

> **NCT04865419** · PHASE1 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 46 (actual)

## Conditions studied

- Haematological Malignancies

## Interventions

- **DRUG:** AZD0466
- **DRUG:** Voriconazole

## Key facts

- **NCT ID:** NCT04865419
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-11
- **Primary completion:** 2023-08-08
- **Final completion:** 2023-08-08
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** Trial terminated based on benefit-risk profile assessment
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04865419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04865419, "Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04865419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*